BIOMAT Database Logo BIOMAT Database Logo

Generation and characterization of an HLA-DR alpha-specific monoclonal antibody using L-cell transfectants expressing human and mouse class II major histocompatibility dimers. 1991

D Palmer, and M Kevany, and C Mackworth-Young, and R Batchelor, and G Lombardi, and R Lechler
Department of Immunology, Royal Postgraduate Medical School, Hammersmith Hospital, England.

Among the HLA-DR-specific monoclonal antibodies (mAbs) that have been characterized previously, there is a marked shortage of DR alpha chain-specific mAbs which stain unfixed cells. This may result from the high degree of sequence similarity between the alpha 1 domains of HLA-DR and H-2E leading to a state of cross-tolerance to DR alpha in H-2-expressing mice. BALB/b (E-negative) mice were immunized with DR1-transfected mouse L cells. The chain specificity of the resulting DR-specific mAb was determined using a panel of transfectants expressing hybrid mouse/human class II heterodimers. A DR alpha-specific mAb was generated which was capable of immunoprecipitating DR alpha beta dimers and inhibiting the anti-DR alloresponse of human T-cell clones. The present study demonstrates that, with the selection of a suitable recipient strain, transfectants can be useful in the generation and definition of chain-specific mouse mAbs.

UI MeSH Term Description Entries
D007114 Immunization Deliberate stimulation of the host's immune response. ACTIVE IMMUNIZATION involves administration of ANTIGENS or IMMUNOLOGIC ADJUVANTS. PASSIVE IMMUNIZATION involves administration of IMMUNE SERA or LYMPHOCYTES or their extracts (e.g., transfer factor, immune RNA) or transplantation of immunocompetent cell producing tissue (thymus or bone marrow). Immunologic Stimulation,Immunostimulation,Sensitization, Immunologic,Variolation,Immunologic Sensitization,Immunological Stimulation,Sensitization, Immunological,Stimulation, Immunologic,Immunizations,Immunological Sensitization,Immunological Sensitizations,Immunological Stimulations,Sensitizations, Immunological,Stimulation, Immunological,Stimulations, Immunological,Variolations
D007739 L Cells A cultured line of C3H mouse FIBROBLASTS that do not adhere to one another and do not express CADHERINS. Earle's Strain L Cells,L Cell Line,L Cells (Cell Line),L-Cell Line,L-Cells,L-Cells, Cell Line,L929 Cell Line,L929 Cells,NCTC Clone 929 Cells,NCTC Clone 929 of Strain L Cells,Strain L Cells,Cell Line L-Cell,Cell Line L-Cells,Cell Line, L,Cell Line, L929,Cell Lines, L,Cell, L,Cell, L (Cell Line),Cell, L929,Cell, Strain L,Cells, L,Cells, L (Cell Line),Cells, L929,Cells, Strain L,L Cell,L Cell (Cell Line),L Cell Lines,L Cell, Strain,L Cells, Cell Line,L Cells, Strain,L-Cell,L-Cell Lines,L-Cell, Cell Line,L929 Cell,Strain L Cell
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D011233 Precipitin Tests Serologic tests in which a positive reaction manifested by visible CHEMICAL PRECIPITATION occurs when a soluble ANTIGEN reacts with its precipitins, i.e., ANTIBODIES that can form a precipitate. Precipitin Test,Test, Precipitin,Tests, Precipitin
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D006684 HLA-DR Antigens A subclass of HLA-D antigens that consist of alpha and beta chains. The inheritance of HLA-DR antigens differs from that of the HLA-DQ ANTIGENS and HLA-DP ANTIGENS. HLA-DR,Antigens, HLA-DR,HLA DR Antigens
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal

Related Publications

D Palmer, and M Kevany, and C Mackworth-Young, and R Batchelor, and G Lombardi, and R Lechler
Analysis of the fine specificities of sheep major histocompatibility complex class II-specific monoclonal antibodies using mouse L-cell transfectants.
April 1995, Animal genetics,
D Palmer, and M Kevany, and C Mackworth-Young, and R Batchelor, and G Lombardi, and R Lechler
Analysis of the molecular specificities of anti-class II monoclonal antibodies by using L cell transfectants expressing HLA class II molecules.
September 1988, Journal of immunology (Baltimore, Md. : 1950),
D Palmer, and M Kevany, and C Mackworth-Young, and R Batchelor, and G Lombardi, and R Lechler
Production and characterization of a peptide specific, anti-major histocompatibility complex class II, monoclonal antibody.
January 1991, Molecular immunology,
D Palmer, and M Kevany, and C Mackworth-Young, and R Batchelor, and G Lombardi, and R Lechler
Epitope mapping of an HLA-DR-specific monoclonal antibody produced by using human-mouse transfectant cells.
December 1989, Journal of immunology (Baltimore, Md. : 1950),
D Palmer, and M Kevany, and C Mackworth-Young, and R Batchelor, and G Lombardi, and R Lechler
Characterization of three separated exons in the HLA class II DR region of the human major histocompatibility complex.
March 1995, Human immunology,
D Palmer, and M Kevany, and C Mackworth-Young, and R Batchelor, and G Lombardi, and R Lechler
Expression of major histocompatibility complex (MHC) class II antigens and HLA-DR incompatibility.
February 1989, Transplantation proceedings,
D Palmer, and M Kevany, and C Mackworth-Young, and R Batchelor, and G Lombardi, and R Lechler
Major histocompatibility complex class II antigen (HLA-DR, DQ and DP) expression in human fetal skin.
July 1986, Tissue antigens,
D Palmer, and M Kevany, and C Mackworth-Young, and R Batchelor, and G Lombardi, and R Lechler
Fine mapping of HLA class II monoclonal antibody specificities using transfected L cells.
January 1990, Immunogenetics,
D Palmer, and M Kevany, and C Mackworth-Young, and R Batchelor, and G Lombardi, and R Lechler
A study of complexes of class II invariant chain peptide: major histocompatibility complex class II molecules using a new complex-specific monoclonal antibody.
February 1996, European journal of immunology,
D Palmer, and M Kevany, and C Mackworth-Young, and R Batchelor, and G Lombardi, and R Lechler
Generation and characterization of a human monoclonal IgG antibody specific for HLA-B12.
July 1994, Tissue antigens,
Copied contents to your clipboard!